Literature DB >> 11760555

NCCN: Non-small cell lung cancer.

D S Ettinger1, M G Kris.   

Abstract

Entities:  

Mesh:

Year:  2001        PMID: 11760555

Source DB:  PubMed          Journal:  Cancer Control        ISSN: 1073-2748            Impact factor:   3.302


× No keyword cloud information.
  6 in total

1.  Survival after community diagnosis of early-stage non-small cell lung cancer.

Authors:  Norma F Kanarek; Craig M Hooker; Luckson Mathieu; Hua-Ling Tsai; Charles M Rudin; James G Herman; Malcolm V Brock
Journal:  Am J Med       Date:  2014-01-28       Impact factor: 4.965

2.  CT-guided implantation of radioactive 125I seed in advanced non-small-cell lung cancer after failure of first-line chemotherapy.

Authors:  Tao Zhang; Mingjian Lu; Sheng Peng; Weidong Zhang; Guang Yang; Zhenyin Liu; Sristi Singh; Yadi Yang; Fujun Zhang; Fei Gao
Journal:  J Cancer Res Clin Oncol       Date:  2014-04-11       Impact factor: 4.553

3.  An integrated genome-wide approach to discover deregulated microRNAs in non-small cell lung cancer: Clinical significance of miR-23b-3p deregulation.

Authors:  Shahnaz Begum; Masamichi Hayashi; Takenori Ogawa; Fayez J Jabboure; Mariana Brait; Evgeny Izumchenko; Sarit Tabak; Steven A Ahrendt; William H Westra; Wayne Koch; David Sidransky; Mohammad O Hoque
Journal:  Sci Rep       Date:  2015-08-28       Impact factor: 4.379

4.  Role of 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in the Diagnosis of Newly Found Suspected Malignant Solitary Pulmonary Lesions in Patients Who Have Received Curative Treatment for Colorectal Cancer.

Authors:  Xiaozhou Yu; Xiuyu Song; Lei Zhu; Wei Chen; Dong Dai; Xiaofeng Li; Wengui Xu
Journal:  Gastroenterol Res Pract       Date:  2017-04-12       Impact factor: 2.260

5.  MicroRNA-17-5p inhibits proliferation and triggers apoptosis in non-small cell lung cancer by targeting transforming growth factor β receptor 2.

Authors:  Hui Li; Hui Zhou; Jiashun Luo; Jun Huang
Journal:  Exp Ther Med       Date:  2017-04-18       Impact factor: 2.447

6.  Salvage treatment of NSCLC recurrence after first-line chemotherapy failure: Iodine-125 seed brachytherapy or microwave ablation?

Authors:  Bin Liu; Yongzheng Wang; Shilin Tian; Yancu Hertzanu; Xiaogang Zhao; Yuliang Li
Journal:  Thorac Cancer       Date:  2020-01-29       Impact factor: 3.500

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.